MedPath

A randomized parallel arm clinical research to assess the effectiveness of homoeopathic medicines Gnaphalium Q vis-a-vis 30C in pain management of case of sciatica.

Phase 1
Conditions
Health Condition 1: G570- Lesion of sciatic nerve
Registration Number
CTRI/2022/09/045243
Lead Sponsor
Dr MPK homeopathic medical college
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Cases symptomatically diagnosed.

2.Cases giving consent to participate in study.

3.Cases with at least 3 symptoms from the following symptoms checklist of:

Low back pain

Buttock pain

Tingling and numbness in legs

Weakness in legs and foot

Exclusion Criteria

1.Immuno-compromised patients such as suffering from HIV, Hepatitis B/C etc.

2.Pregnant women and lactating mothers will not be included in the study.

3. Cases with multi systemic illness will be excluded from the study and cases with advanced pathology.

4.Patients who are not willing to give informed consent.

5.Patients taking other treatments for Sciatica.

6.The cases associated with severe irreversible pathological condition of spinal cord or nerve were excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
from this study, we expect that homoeopathy medicine will work in cases of sciaticaTimepoint: pre and post vas scale score will be assesed at the end of 12 weeks
Secondary Outcome Measures
NameTimeMethod
to assess the role of homeopathic medicines in cases of sciaticaTimepoint: 12 months
© Copyright 2025. All Rights Reserved by MedPath